Related Experiment Video
Updated: Oct 26, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK?
1Microbiology Department, Queens Medical Centre, Nottingham University Hospitals Trust, Derby Road, Nottingham NG7 2UH, UK.
Abstract:
Vancomycin remains a useful agent in the infection doctor's toolkit, particularly for Staphylococcus aureus and MRSA infections. Therapeutic drug monitoring (TDM) is essential to maintain efficacy and avoid toxicity. Until recently, trough-based dosing has been the recommended method but in recent years the reliability of this has been questioned. The 2020 Infectious Diseases Society of America (IDSA) vancomycin guideline update has sent a clear message that trough-based dosing is not to be relied on, instead recommending dosing via 24 h AUC/MIC. The UK, however, has yet to follow suit in this, despite the wealth of evidence showing that trough-based dosing puts patients at higher risk of nephrotoxicity. Clearly, it is time to incorporate AUC/MIC-based dosing to utilize this effective antibiotic safely.
Insights
Vancomycin dosing should shift from trough-based to 24-hour AUC/MIC monitoring for improved efficacy and reduced nephrotoxicity. This change is crucial for safe vancomycin use, especially for MRSA infections.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Vancomycin is vital for treating Staphylococcus aureus and MRSA infections.
- Therapeutic drug monitoring (TDM) is essential for vancomycin efficacy and safety.
- Trough-based dosing, previously standard, faces scrutiny regarding reliability and patient risk.
Purpose of the Study:
- To advocate for the adoption of 24-hour AUC/MIC-based vancomycin dosing.
- To highlight the risks associated with continued reliance on trough-based dosing, particularly nephrotoxicity.
- To align UK vancomycin dosing practices with international guidelines.
Main Methods:
- Review of current vancomycin dosing guidelines and evidence.
- Analysis of the risks and benefits of trough-based versus AUC/MIC-based dosing.
- Comparison of UK practices with international recommendations (e.g., IDSA 2020 guidelines).
Main Results:
- The 2020 IDSA guidelines recommend 24-hour AUC/MIC dosing over trough-based methods.
- Evidence indicates trough-based dosing increases the risk of vancomycin-induced nephrotoxicity.
- The UK has not yet fully implemented AUC/MIC-based dosing, lagging behind evidence-based recommendations.
Conclusions:
- Transitioning to AUC/MIC-based vancomycin dosing is necessary for patient safety.
- Implementing AUC/MIC dosing will optimize vancomycin efficacy and minimize toxicity.
- Adopting AUC/MIC dosing aligns clinical practice with current scientific evidence and guidelines.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Dosing: Infants and Children
Drug Dosing: Geriatric Patients
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Dosage Interval and Administration Route: Determination Methods

